arrow
O

Olav Dalgård

karolinska institutet
H指数:47
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hepatic flares, their immune signatures, and ALT variability after nucleos(t)ide analogue cessation in HBeAg-negative hepatitis B

HBeAg阴性乙型肝炎患者核苷(酸)类似物停药后的肝功能flare、免疫特征及ALT变异性

2026-06-011
OA
Antibiotic therapy in viral airway infections (ATHENIAN): study protocol for an open labeled randomized controlled pragmatic trial to evaluate the efficacy and safety of discontinuing antibiotic therapy in adult patients infected with respiratory viruses

病毒性呼吸道感染中的抗生素治疗(ATHENIAN):一项开放标签随机对照实用试验研究方案,旨在评估终止抗生素治疗在感染呼吸道病毒成人患者中的有效性和安全性

2026-04-210
PRE
Clinical trial: An open-label, randomised trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B
2024-07-055
OAAI
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial
2024-03-014
OA
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (vol 12, 2349, 2021)

羟氯喹和氯喹在新型冠状病毒肺炎中的死亡率结果: 一项随机试验的国际合作荟萃分析 (第12卷,2349,2021卷)

2024-02-050
OAAI